US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetic patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies.
Express Scripts files suit against FTC, demands retraction of report on PBM industry
Express Scripts has filed suit against the Federal Trade Commission, demanding that the agency retract a damning report on the pharmacy benefit management industry. | Express Scripts has filed suit against the Federal Trade Commission,
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.
The complaint alleges that Optum Rx, Express Scripts and Caremark — all vertically integrated with UnitedHealth Group, ...
Insulin, used by millions of Americans, has taken center stage in the high-stakes battle over health care costs. Though prescribed for the past 100 years, only three companies supply insulin in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback